ArticlePloS one2021

Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study.

Hsu-Heng Yen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.